Otto Loewi Research Center, Pharmacology Section, Medical University of Graz, Universitätsplatz 4, A-8010, Graz, Austria; Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, A-8036, Graz, Austria.
Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, A-8036, Graz, Austria.
Int J Surg. 2020 Mar;75:160-164. doi: 10.1016/j.ijsu.2020.01.146. Epub 2020 Feb 7.
Nodal clearance was recommended after positive sentinel lymph node biopsy (SLNB) despite further metastases to the regional lymph node basin being found in only 6-21% in the literature. This retrospective study was conducted to determine the role of the time interval between excision of primary melanoma and confirmed metastasis in the sentinel lymph node biopsy as well as the one between positive sentinel lymph node biopsy (SLNB-positive patients) and subsequent completion lymph node dissection (CLND) on the presence of metastases. The monocentric analysis included 121 patients with a history of completion lymph node dissection after positive SLNB from January 2005 to October 2013. Additional metastases in the regional lymph node basin (non-sentinels) were found in 14.05% (n = 17). Significant risk factors for the presence of metastases in CLND were the time between confirmed primary tumour to metastasis in sentinel lymph nodes (SLN) (p = 0.0034), N-category of TNM-classification (p = 0.0066) and independent of thickness of primary tumour (p = 0.11). If SLNB was performed up to forty-three days after confirmed primary melanoma, subsequent lymph node dissection was positive in less than 9.1%. When SLNB was performed with a delay of more than 80 days, all patients had metastases in the CLND specimens. Our data analysis suggests that delays in subsequent procedures of SLNB after diagnosis of primary melanoma may have a greater impact on positivity of non-sentinel lymph nodes than previously assumed. Our retrospective analysis may indicate the reconsideration of time schedule in the management of primary melanoma to potentially avoid local relapse in the draining lymph node region after positive SLNB.
尽管文献报道仅在 6-21%的情况下进一步发现区域淋巴结盆转移,但仍建议在阳性前哨淋巴结活检(SLNB)后进行淋巴结清扫。本回顾性研究旨在确定原发性黑素瘤切除与前哨淋巴结活检中证实转移之间的时间间隔以及 SLNB 阳性(SLNB 阳性患者)与随后完成淋巴结清扫术(CLND)之间的时间间隔对转移存在的影响。该单中心分析包括 2005 年 1 月至 2013 年 10 月期间接受 CLND 后阳性 SLNB 的 121 例患者。在区域淋巴结盆(非前哨)中发现额外转移的占 14.05%(n=17)。CLND 中存在转移的显著危险因素包括确认原发性肿瘤至前哨淋巴结(SLN)转移之间的时间(p=0.0034)、TNM 分类的 N 分期(p=0.0066)和独立于原发性肿瘤厚度(p=0.11)。如果 SLNB 在确认原发性黑素瘤后 43 天内进行,随后的淋巴结清扫术阳性率低于 9.1%。如果 SLNB 延迟超过 80 天进行,所有患者在 CLND 标本中均有转移。我们的数据分析表明,原发性黑素瘤诊断后 SLNB 后续治疗的延迟可能对非前哨淋巴结的阳性率产生比之前假设更大的影响。我们的回顾性分析可能表明,需要重新考虑原发性黑素瘤管理的时间安排,以潜在避免 SLNB 阳性后引流淋巴结区域的局部复发。